Main news

CLC bio is currently ramping up their efforts in both North and South America as a direct response to the increasing data analysis demands throughout the life science sector. Per September 1st, CLC bio’s Americas headquarters has opened a new location on 10 Rogers Street in Cambridge, Boston.

With the intention to better support education and academics, CLC bio today announced that the prices of its world leading DNA, RNA, and Protein sequence analysis software packages are reduced by 50% for academic customers.

RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next generation DNA sequencing platforms.

CLC bio has just completed a specialized immunoinformatics solution that is fully customized to fit into Symphogen’s proprietary Symplex™ technology for high throughput identification of antibodies with diversity and specificity customized to a particular therapeutic application.

The University of Queensland and CLC bio have signed an agreement, providing each student enrolled in the university’s genetics courses with a copy of CLC Main Workbench, worth more than $2 million USD over four years.